New Ovarian Cancer Drug Extends Survival in Resistant Disease

(MedPage Today) -- CHICAGO -- An antibody-microtubule inhibitor conjugate improved survival in selected patients with advanced platinum-resistant ovarian cancer compared with standard chemotherapy, representing the first novel drug to do so in...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news